Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting in April, providers with a Quest account will be able to order ...
Add Yahoo as a preferred source to see more of our stories on Google. A simple blood test may reveal your 10-year risk of liver disease. (CREDIT: Shutterstock) Cirrhosis and liver cancer are two of ...
WEDNESDAY, March 19, 2026 (HealthDay News) — Fatty liver disease is when too much fat builds up in the liver. The liver is the body’s filter. It helps clean your blood, store energy and process ...
Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced an agreement with Quest Diagnostics, a leading provider of diagnostic information services, to ...
Researchers have recently created a blood test that can detect liver disease years before symptoms ever develop, helping pave the way for the diagnosis of diseases such as cirrhosis and liver cancer ...
Cancer diagnostics firm Helio Genomics says its five-year clinical trial shows its AI-based diagnostic test is two to four times more effective than typical ultrasounds. Helio’s pivotal trial, which ...
A recent study at the Medical University of South Carolina's (MUSC) Digestive Disease Research Core Center (DDRCC) provides insight into why physicians should be cautious when using a certain liver ...
Please provide your email address to receive an email when new articles are posted on . Intelligent liver function testing successfully identified patients with hepatitis C who were previously ...
An intelligent liver function test platform (iLFT) successfully integrated into one Scottish primary care system reduced unnecessary specialist referrals over a 5-year period, and improved triage for ...
The Manila Times on MSN
Health supplement brand offers fatty liver test for free
AN over-the-counter health supplement brand has encouraged the public to take advantage of free liver testing as part of an initiative to improve access to early screening among Filipinos. In a ...
In a cohort study of nearly 16,000 US patients with breast cancer who were prescribed a cyclin-dependent kinase (CDK) 4/6 inhibitor, only 46% underwent liver function testing in the 2 weeks before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results